201 related articles for article (PubMed ID: 37741962)
1. Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment.
Qiu L; Shen R; Wei L; Xu S; Xia W; Hou Y; Cui J; Qu R; Luo J; Cao J; Yang J; Sun J; Ma R; Yu Q
J Nanobiotechnology; 2023 Sep; 21(1):344. PubMed ID: 37741962
[TBL] [Abstract][Full Text] [Related]
2. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.
Zhu Y; Xu Y; Wang X; Rao L; Yan X; Gao R; Shen T; Zhou Y; Kong C; Zhou L
Front Cell Infect Microbiol; 2022; 12():886061. PubMed ID: 35782138
[TBL] [Abstract][Full Text] [Related]
4. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease.
Rose DJ; Venema K; Keshavarzian A; Hamaker BR
Br J Nutr; 2010 May; 103(10):1514-24. PubMed ID: 20021704
[TBL] [Abstract][Full Text] [Related]
5. Alginate Alleviates Dextran Sulfate Sodium-Induced Colitis by Promoting Bifidobacterium animalis and Intestinal Hyodeoxycholic Acid Synthesis in Mice.
Pi Y; Zhang X; Wu Y; Wang Z; Bai Y; Liu X; Han D; Zhao J; Tobin I; Zhao J; Zhang G; Wang J
Microbiol Spectr; 2022 Dec; 10(6):e0297922. PubMed ID: 36219101
[TBL] [Abstract][Full Text] [Related]
6. Colon-Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora.
Liu H; Cai Z; Wang F; Hong L; Deng L; Zhong J; Wang Z; Cui W
Adv Sci (Weinh); 2021 Sep; 8(18):e2101619. PubMed ID: 34292669
[TBL] [Abstract][Full Text] [Related]
7. Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.
Rasmussen HE; Hamaker B; Rajan KB; Mutlu E; Green SJ; Brown M; Kaur A; Keshavarzian A
Nutr Res; 2017 Aug; 44():27-37. PubMed ID: 28821315
[TBL] [Abstract][Full Text] [Related]
8. Fermentation of alginate and its derivatives by different enterotypes of human gut microbiota: Towards personalized nutrition using enterotype-specific dietary fibers.
Fu T; Pan L; Shang Q; Yu G
Int J Biol Macromol; 2021 Jul; 183():1649-1659. PubMed ID: 34048831
[TBL] [Abstract][Full Text] [Related]
9. Fuzhuan brick tea polysaccharides serve as a promising candidate for remodeling the gut microbiota from colitis subjects in vitro: Fermentation characteristic and anti-inflammatory activity.
Chen G; Wang M; Zeng Z; Xie M; Xu W; Peng Y; Zhou W; Sun Y; Zeng X; Liu Z
Food Chem; 2022 Oct; 391():133203. PubMed ID: 35597036
[TBL] [Abstract][Full Text] [Related]
10. Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients.
Armstrong HK; Bording-Jorgensen M; Santer DM; Zhang Z; Valcheva R; Rieger AM; Sung-Ho Kim J; Dijk SI; Mahmood R; Ogungbola O; Jovel J; Moreau F; Gorman H; Dickner R; Jerasi J; Mander IK; Lafleur D; Cheng C; Petrova A; Jeanson TL; Mason A; Sergi CM; Levine A; Chadee K; Armstrong D; Rauscher S; Bernstein CN; Carroll MW; Huynh HQ; Walter J; Madsen KL; Dieleman LA; Wine E
Gastroenterology; 2023 Feb; 164(2):228-240. PubMed ID: 36183751
[TBL] [Abstract][Full Text] [Related]
11. The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: A multi-center study.
Khoo XH; Chong CW; Talha AM; Philip K; Teh CS; Isa AM; Wong MS; Chew DC; Wong Z; Jusoh NS; Maksum NMM; Mokhtar NM; Majid HA; Ali RAR; Lee YY; Mahadeva S
J Gastroenterol Hepatol; 2023 Aug; 38(8):1259-1268. PubMed ID: 36908030
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic Preparation of pH-Responsive Microsphere Fibers and Their Controlled Drug Release Properties.
Wang N; Wei Y; Hu Y; Sun X; Wang X
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202775
[TBL] [Abstract][Full Text] [Related]
13. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
[TBL] [Abstract][Full Text] [Related]
14. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model.
Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L
Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Commonly Consumed Dietary Fibres on the Gut Microbiome and Its Fibre Fermentative Capacity in Adults with Inflammatory Bowel Disease in Remission.
Gerasimidis K; Nichols B; McGowan M; Svolos V; Papadopoulou R; Kokkorou M; Rebull M; Bello Gonzalez T; Hansen R; Russell RK; Gaya DR
Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268028
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
17. The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.
Tuck CJ; Caminero A; Jiménez Vargas NN; Soltys CL; Jaramillo Polanco JO; Lopez Lopez CD; Constante M; Lourenssen SR; Verdu EF; Muir JG; Lomax AE; Reed DE; Vanner SJ
Neurogastroenterol Motil; 2019 Oct; 31(10):e13675. PubMed ID: 31290223
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid).
Klotz U
Arzneimittelforschung; 2012 Feb; 62(2):53-8. PubMed ID: 22344548
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z
Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis.
Wada H; Miyoshi J; Kuronuma S; Nishinarita Y; Oguri N; Hibi N; Takeuchi O; Akimoto Y; Lee STM; Matsuura M; Kobayashi T; Hibi T; Hisamatsu T
Sci Rep; 2023 Jul; 13(1):12241. PubMed ID: 37507482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
